MBP1: A novel mutant p53-specific protein partner with oncogenic properties

Oncogene

Volumn 18, Issue 24, 1999, Pages 3608-3616

  Gallagher, William M ^a   Argentini, Manuela ^b   Sierra, Véronique ^a   Bracco, Laurent ^c   Debussche, Laurent ^a   Conseiller, Emmanuel ^a  

^a SANOFI   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c ExonHit Therapeutics   (France)

Author keywords

Fibulin; Gain of function; MBP1; Mutant p53

Indexed keywords

BINDING PROTEIN; MESSENGER RNA; MUTANT PROTEIN; PROTEIN P53;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAMMAL CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR GROWTH; YEAST;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM-BINDING PROTEINS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; EMBRYO; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN CONFORMATION; RNA, MESSENGER; SEQUENCE DELETION; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; YEASTS;

ANIMALIA; MAMMALIA;

EID: 0033577993     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202937     Document Type: Article

References (39)

1. Blandino G, Levine AJ and Oren M. (1999). Oncogene, 18, 477-485.
2. Blobel G. (1980). Proc. Natl. Acad. Sci. USA, 77, 1496-1500.
3. Campbell ID and Bork P. (1993). Curr. Opin. Struct. Biol., 3, 385-392.
4. Chevray PM and Nathans D. (1992). Proc. Natl. Acad. Sci. USA, 89, 5789-5793.
5. Chen Y, Chen P-L and Lee W-H. (1994). Mol. Cell. Biol., 14, 6764-6772.
6. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
7. Delahunty M and Bonifacino JS. (1995). Connective Tissue Res., 31, 283-286.
8. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. (1993). Nature Genet., 4, 42-46.
9. Fields S and Song O-K. (1989). Nature, 340, 245-246.
10. Finlay C. (1995). Methods Enzymol., 255, 389-394.
11. Fritsche M, Mundt M, Merkle C, Jahne R and Groner B. (1998). Mol. Cell. Endocrin., 143, 143-154.
12. Gallagher WM and Brown R. (1999). Ann. Oncol., 10, 139-150.
13. Gietz RD, Schiestl RH, Willems AR and Woods RA. (1995). Yeast, 11, 355-360.
14. Gloushankova N, Ossovskaya V, Vasiliev J, Chumakov P and Kopnin B. (1997). Oncogene, 15, 2985-2989.
15. Greenblatt MS, Bennet WP, Hollstein M and Harris CC. (1994). Cancer Res., 54, 4855-4878.
16. Harvey M, Vogel H, Morris D, Bradley A, Berstein A and Donehower LA. (1995). Nature Genet., 9, 305-311.
17. Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves WS and Rochefort H. (1998). Int. J. Cancer, 75, 654-658.
18. Hinds PW, Finlay CA. Quartin RS, Baker SJ, Fearon ER, Vogelstein B and Levine AJ. (1990). Cell Growth Diff., 1, 571-580.
19. Hsiao M, Low J, Dorn E, Ku D, Pattengale P, Yeargin J and Haas M. (1994). Am. J. Pathol., 145, 702-714.
20. Iwabuchi K, Li B, Bartel P and Fields S. (1993). Oncogene, 8, 1693-1696.
21. Lecka-Czernik B, Lumpkin CK and Goldslein S. (1995). Mol. Cell. Biol., 15, 120-128.
22. Li B, Murphy KL, Laucirica R, Kittrell F, Medina D and Rosen JM. (1998). Oncogene, 16, 997-1007.
23. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD and Shuai K. (1998). Proc. Natl. Acad. Sci. USA, 95, 10626-10631.
24. Merrick BA, He C, Witcher LL, Patterson RM, Reid JJ, Pence-Pawlowski PM and Selkirk JK. (1996). Biochim. Biophys. Acta, 1297, 57-68.
25. Milner J and Medcalf EA. (1991). Cell, 65, 765-774.
26. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD and Gazdar AF. (1992). Oncogene, 7, 171-180.
27. Nelson V and Maxwell SA. (1999), Proc. Am. Assoc. Cancer Res., 40, 695.
28. Quelle FW, Wang J, Feng J, Wang D, Clevel and JL, Ihle JN and Zambetti GP. (1998). Genes Dev., 12, 1099-1107.
29. Qing J, Maher VM, Tran H, Argraves WS, Dunstan RW and McCormick JJ. (1997). Oncogene, 15, 2159-2168.
30. Roger P, Pujol P, Lucas A, Baldet P and Rochefort H. (1998). Am. J. Pathol., 153, 1579-1588.
31. Sakaguchi M, Tomiyoshi R, Kuroiwa T, Mihara K and Omura T. (1992). Proc. Natl. Acad. Sci. USA, 89, 16-19.
32. Saltzman A, Searfoss G, Marcireau C, Stone M, Ressner R, Munro R, Franks C, D'Alonzo J, Tocque B, Jaye M and Ivashehenko Y. (1998). FEBS Lett., 425, 431-435.
33. Scheffner M. (1998). Pharmacol. Ther., 78, 129-139.
34. Shen Z, Pardington-Purtymun PE, Comeaux JC, Moyzis RK and Chen DJ. (1996). Genomics, 37, 183-186.
35. Toh H, Urade Y and Tanabe T. (1992). Mediators of Inflammation, 1, 223-233.
36. Tran H, Mattei M, Godyna S and Argraves WS. (1997). Matrix Biol., 15, 479-493.
37. Valdez BC, Henning D, Perlaky L, Busch RK and Busch H. (1997). Biochem. Biophys. Res. Comm., 234, 335-340.
38. Walker KK and Levine AJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 15335-15340.
39. Zambetti GP and Levine AJ. (1993). FASEB J., 7, 855-865.